GlassScriptPhysician profile
James C Gilmore
NPI 1477560050
$1,560.03
in general payments reported to CMS, 2019-2025
22 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.88 · 2020: $85.95 · 2021: $103 · 2022: $152 · 2023: $135 · 2024: $748 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $337.73 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Electromed, INC. | $210.60 | 2024 | Smartvest |
| Abiomed | $166.85 | 2024-2025 | Impella |
| Davol INC. | $143.68 | 2025 | Arista |
| Intuitive Surgical, INC. | $134.85 | 2021-2023 | Da Vinci Surgical System |
| Pfizer INC. | $74.67 | 2020-2022 | |
| Daxor Corporation | $68.34 | 2023 | Bva-100 |
| Medtronic, INC. | $60.86 | 2021-2024 | Interstim |
| Boston Scientific Corporation | $42.60 | 2025 | Enroute Transcarotid Stent |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $41.60 | 2025 | |
| United Therapeutics Corporation | $36.20 | 2023-2024 | Tyvaso |
| Janssen Pharmaceuticals, INC | $35.89 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $34.57 | 2021-2024 | Ribfix Blu Advantage |
| Edwards Lifesciences Corporation | $30.00 | 2022 | |
| Ge Healthcare | $24.09 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $23.90 | 2021 | |
| Lemaitre Vascular, INC. | $20.86 | 2022 | |
| Atricure, INC. | $16.46 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.93 | 2024 | Lifevest |
| Veran Medical Technologies, INC. | $15.88 | 2019 | |
| Medtronic Vascular, INC. | $13.10 | 2020 | |
| Chiesi USA, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gilmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.